1-4 of 4
Piet Ost
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts

Jack Andrews, Yohan Kim, Edlira Horjeti, Ali Arafa, Heather Gunn, Aurélie De Bruycker, Ryan Phillips, Daniel Song, Daniel S. Childs, Oliver A. Sartor, Jacob J. Orme, Aadel A. Chaudhuri, Phuoc Tran, Ana Kiess, Philip Sutera, Carole Mercier, Piet Ost, Sean S. Park, Fabrice Lucien-Matteoni
Journal: Clinical Cancer Research
Clin Cancer Res (2025)
https://doi.org/10.1158/1078-0432.CCR-24-3027
Published: 16 January 2025
View article titled, PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts
Open the PDF for PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts in another window
Includes: Supplementary data
Journal Articles

Abstract A007: Circulating tumor DNA and tissue staining analyses reveal heterogeneous ERBB2/HER2 status in urothelial cancer

Gillian Vandekerkhove, Andrew J. Murtha, David C. Müller, Kimia Rostin, Carlos Vasquez-Rios, Jussi Nikkola, Maria Stephenson, Emily Fung, Jaskirat Atwal, Karan Parekh, Cecily Q. Bernales, Gráinne Donnellan, Gang Wang, Tilman Todenhöfer, Piet Ost, Peter C. Black, Kim N. Chi, Bernhard J. Eigl, Alexander W. Wyatt
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10_Supplement): A007.
https://doi.org/10.1158/1557-3265.BLADDER24-A007
Published: 17 May 2024
View article titled, Abstract A007: Circulating tumor DNA and tissue staining analyses reveal heterogeneous <em>ERBB2</em>/HER2 status in urothelial cancer
Journal Articles

Abstract PR08: The genomic landscape of metastatic urothelial carcinoma from circulating tumor DNA

Gillian R. Vandekerkhove, Matti Annala, Jean-Michel Lavoie, Nora Sundahl, Simon Walz, Takeshi Sano, Andrew Murtha, Tilman Todenhöfer, Piet Ost, Kim N. Chi, Peter C. Black, Bernhard Eigl, Alexander W. Wyatt
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): PR08.
https://doi.org/10.1158/1557-3265.BLADDER19-PR08
Published: 03 August 2020
View article titled, Abstract PR08: The genomic landscape of metastatic urothelial carcinoma from circulating tumor DNA
Journal Articles

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Bram De Laere, Steffi Oeyen, Markus Mayrhofer, Tom Whitington, Pieter-Jan van Dam, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey, Lucien Hoekx, Dirk Schrijvers, Barbara Brouwers, Willem Lybaert, Els G. Everaert, Daan De Maeseneer, Michiel Strijbos, Alain Bols, Karen Fransis, Nick Beije, Inge E. de Kruijff, Valerie van Dam, Anja Brouwer, Dirk Goossens, Lien Heyrman, Gert G. Van den Eynden, Annemie Rutten, Jurgen Del Favero, Mattias Rantalainen, Prabhakar Rajan, Stefan Sleijfer, Anders Ullén, Jeffrey Yachnin, Henrik Grönberg, Steven J. Van Laere, Johan Lindberg, Luc Y. Dirix
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (6): 1766–1773.
https://doi.org/10.1158/1078-0432.CCR-18-1943
Published: 15 March 2019
View article titled, <em>TP53</em> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
Open the PDF for <em>TP53</em> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data